Beinaglutide is another short-acting recombinant human GLP-1RA that closely resembles human GLP-1(6-37), approved in China for the indications of type 2 diabetes mellitus and weight loss
Lttl's main pricing hook concerns dose changes
In a 2024 report, Senator Bernie Sanders, a Vermont Independent and chairman of the Senate Health, Education, Labor, and Pensions Committee, pointed out that if half of adults with obesity took Wegovy and other new weight loss drugs, the cost at the time $411 billion per year would exceed what Americans spent on all retail prescription drugs in 2022 $406 billion
Public beliefs about the causes of obesity and attitudes towards policy initiatives in Great Britain
With IVIM, the feedback loop is compressed to seven days, which means problems get caught and addressed faster
July 2006